Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
AUPH · NASDAQ · Pharmaceutical Preparations
$14.70−0.19 (−1.28%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Aurinia Pharmaceuticals (AUPH) · oqro.io/stocks/AUPH · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Officer sold ~$190K of AUPH shares in the open marketSourceInsider trade · Traded Aug 1, 2025 · Filed Aug 5, 2025
Director purchased ~$10.1M of AUPH shares in the open marketSourceInsider trade · Traded Aug 5, 2025 · Filed Aug 5, 2025
Director purchased ~$2.34M of AUPH shares in the open marketSourceInsider trade · Traded Aug 4, 2025 · Filed Aug 5, 2025
Director purchased ~$1.13M of AUPH shares in the open marketSourceInsider trade · Traded Aug 1, 2025 · Filed Aug 5, 2025
Officer sold ~$210K of AUPH shares in the open marketSourceInsider trade · Traded Mar 7, 2025 · Filed Mar 7, 2025
Officer sold ~$68K of AUPH shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 5, 2025
CEO sold ~$1.56M of AUPH shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 5, 2025
CEO sold ~$1.31M of AUPH shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 5, 2025
CFO sold ~$495K of AUPH shares in the open marketSourceInsider trade · Traded Dec 5, 2024 · Filed Dec 9, 2024
Director purchased ~$2.67M of AUPH shares in the open marketSourceInsider trade · Traded Dec 9, 2024 · Filed Dec 9, 2024
Director purchased ~$4.54M of AUPH shares in the open marketSourceInsider trade · Traded Dec 6, 2024 · Filed Dec 9, 2024
Director purchased ~$3.6M of AUPH shares in the open marketSourceInsider trade · Traded Nov 11, 2024 · Filed Nov 13, 2024
Director sold ~$44K of AUPH shares in the open marketSourceInsider trade · Traded Nov 11, 2024 · Filed Nov 13, 2024
Director sold ~$38K of AUPH shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 5, 2025
CFO sold ~$445K of AUPH shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 5, 2025
Officer sold ~$527K of AUPH shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 5, 2025
Officer sold ~$519K of AUPH shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 5, 2025
Officer sold ~$467K of AUPH shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 5, 2025
Officer sold ~$456K of AUPH shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 5, 2025
Officer sold ~$98K of AUPH shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 4, 2025
Director purchased ~$3.96M of AUPH shares in the open marketSourceInsider trade · Traded Feb 28, 2025 · Filed Mar 4, 2025
Director purchased ~$3.13M of AUPH shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 4, 2025
Director purchased ~$2.82M of AUPH shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 4, 2025
Director purchased ~$1.18M of AUPH shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 4, 2025
Director purchased ~$803K of AUPH shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 4, 2025
Director purchased ~$809K of AUPH shares in the open marketSource